PortfoliosLab logo
KRMD vs. LUNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between KRMD and LUNA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

KRMD vs. LUNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Repro Med Systems, Inc. (KRMD) and Luna Innovations Incorporated (LUNA). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

KRMD:

183.35%

LUNA:

71.97%

Max Drawdown

KRMD:

-4.26%

LUNA:

-4.94%

Current Drawdown

KRMD:

-4.26%

LUNA:

-1.23%

Fundamentals

Market Cap

KRMD:

$145.34M

LUNA:

$13.88M

EPS

KRMD:

-$0.13

LUNA:

-$0.03

PS Ratio

KRMD:

4.32

LUNA:

0.12

PB Ratio

KRMD:

8.64

LUNA:

0.15

Returns By Period


KRMD

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

LUNA

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

KRMD vs. LUNA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRMD
The Risk-Adjusted Performance Rank of KRMD is 7272
Overall Rank
The Sharpe Ratio Rank of KRMD is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of KRMD is 7575
Sortino Ratio Rank
The Omega Ratio Rank of KRMD is 7070
Omega Ratio Rank
The Calmar Ratio Rank of KRMD is 7272
Calmar Ratio Rank
The Martin Ratio Rank of KRMD is 7171
Martin Ratio Rank

LUNA
The Risk-Adjusted Performance Rank of LUNA is 1212
Overall Rank
The Sharpe Ratio Rank of LUNA is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of LUNA is 1717
Sortino Ratio Rank
The Omega Ratio Rank of LUNA is 1515
Omega Ratio Rank
The Calmar Ratio Rank of LUNA is 33
Calmar Ratio Rank
The Martin Ratio Rank of LUNA is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

KRMD vs. LUNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Repro Med Systems, Inc. (KRMD) and Luna Innovations Incorporated (LUNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

KRMD vs. LUNA - Dividend Comparison

Neither KRMD nor LUNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

KRMD vs. LUNA - Drawdown Comparison

The maximum KRMD drawdown since its inception was -4.26%, smaller than the maximum LUNA drawdown of -4.94%. Use the drawdown chart below to compare losses from any high point for KRMD and LUNA. For additional features, visit the drawdowns tool.


Loading data...

Volatility

KRMD vs. LUNA - Volatility Comparison


Loading data...

Financials

KRMD vs. LUNA - Financials Comparison

This section allows you to compare key financial metrics between Repro Med Systems, Inc. and Luna Innovations Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00M10.00M15.00M20.00M25.00M30.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
8.84M
30.70M
(KRMD) Total Revenue
(LUNA) Total Revenue
Values in USD except per share items